Letter

Secondary prevention for stroke and transient ischaemic attacks

BMJ 2004; 328 doi: 10.1136/bmj.328.7444.896-b (Published 8 April 2004)
Cite this as: BMJ 2004;328:896.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

PROGRESS is about reducing blood pressure, not promoting drugs

  1. Martin Duerden, general practitioner (martin@theduerdens.co.uk)
  1. Meddygfa Gyffin, Conwy, North Wales LL32 8LT

    EDITOR—In his editorial Muir argues for the combination of perindopril and indapamide as preferred agents for lowering blood pressure after stroke or transient ischaemic attack on the basis of the perindopril protection against recurrent stroke study (PROGRESS).1 Is this justified? PROGRESS did not compare regimens; other evidence shows that lowering blood pressure …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular